Related Experiment Video
Updated: Jun 11, 2026

Pentylenetetrazole-Induced Kindling Mouse Model
Published on: June 12, 2018
Enhanced oxidative stress and impaired antioxidant defense in drug-resistant epilepsy
Caner Baydar1, Abdullah Yılgör1
1Department of Neurology, Yuzuncu Yıl University School of Medicine, Van, Turkey.
Background:
Oxidative stress is increasingly recognized as a key contributor to epileptogenesis and seizure-related neuronal injury, particularly in drug-resistant epilepsy (DRE). Persistent seizures may promote cumulative oxidative damage; however, comprehensive evaluation of ischemia-related stress, antioxidant capacity, and protein oxidation in DRE remains limited.
Objective:
To comprehensively assess oxidative stress status in patients with drug-resistant epilepsy by measuring ischemia-modified albumin (IMA), total sulfhydryl (TSH) levels, and protein carbonyl (PC) concentrations.
Methods:
In this cross-sectional study, serum IMA, TSH, and PC levels were measured in patients with drug-resistant epilepsy and age- and sex-matched healthy controls using standardized spectrophotometric methods. Between-group comparisons were performed to characterize oxidative imbalance associated with DRE.
Results:
Thirty-three patients with drug-resistant epilepsy and 32 healthy controls were included. Serum IMA levels were significantly higher in patients with drug-resistant epilepsy than in controls (2.07 ± 0.02 vs 1.04 ± 0.02 AU, p < 0.001). Similarly, protein carbonyl levels were significantly elevated (0.49 ± 0.02 vs 0.24 ± 0.03 µmol/mL serum, p < 0.001), whereas total sulfhydryl levels were significantly reduced (3.17 ± 0.03 vs 6.34 ± 0.10 nmol/mg protein, p < 0.001). These findings collectively indicate a marked shift toward a pro-oxidative state in drug-resistant epilepsy.
Conclusion:
Drug-resistant epilepsy is associated with enhanced oxidative stress characterized by ischemia-related modification, irreversible protein oxidation, and depletion of antioxidant defenses. The combined assessment of IMA, TSH, and PC provides an integrated biochemical profile of oxidative imbalance in DRE and may contribute to a better understanding of seizure-related neurobiological mechanisms. These findings may provide insights for future research on therapeutic strategies targeting oxidative pathways.
Related Concept Videos
Epilepsy and Seizures: Overview
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Antiepileptic Drugs: Potassium Channel Activators
Ezogabine has gained approval as an adjunctive treatment...
Drug Toxicity: Risk factors
Antiepileptic Drugs: Glutamate Antagonists
Antiepileptic Drugs: GABAergic Pathway Potentiators
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for their...
Electron Transport Chain: Complex I and II
ROS generation is regulated and maintained at moderate levels necessary...
